|
1
|
Nicholson KG, Wood JM and Zambon M:
Influenza. Lancet. 362:1733–1745. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Trifonov V, Khiabanian H, Greenbaum B and
Rabadan R: The origin of the recent swine influenza seasonal
influenza A(H1N1) virus infecting humans. Euro Surveill.
14:191932009.PubMed/NCBI
|
|
3
|
Centers for Disease Control and Prevention
(CDC). Update: Infections with a Swine-Origin Influenza A (H1N1)
Virus, United States and other countries. 2009, http://www.cdc.gov/mmwr.
|
|
4
|
Hayden FG and Hay AJ: Emergence and
transmission of influenza A viruses resistant to amantadine and
rimantadine. Curr Top Microbiol Immunol. 176:119–130.
1992.PubMed/NCBI
|
|
5
|
de Jong MD, Tran TT, Truong HK, Vo MH,
Smith GJ, Nguyen VC, Bach VC, Phan TQ, Do QH, Guan Y, Peiris JS,
Tran TH and Farrar J: Oseltamivir resistance during treatment of
influenza A (H5N1) infection. N Engl J Med. 353:2667–2672.
2005.
|
|
6
|
Deyde VM, Xu X, Bright RA, Shaw M, Smith
CB, Zhang Y, Shu Y, Gubareva LV, Cox NJ and Klimov AI: Surveillance
of resistance to adamantanes among influenza A (H3N2) and A (H1N1)
viruses isolated worldwide. J Infect Dis. 196:249–257. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Le QM, Kiso M, Someya K, Sakai YT, Nguyen
TH, Nguyen KH, Pham ND, Ngyen HH, Yamada S, Muramoto Y, Horimoto T,
Takada A, Goto H, Suzuki T, Suzuki Y and Kawaoka Y: Avian flu:
isolation of drug-resistant H5N1 virus. Nature. 437:11082005.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Shetty AK and Peek LA: Peramivir for the
treatment of influenza. Expert Rev Anti Infect Ther. 10:123–143.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chang YS and Ho YL: Studies on the
homonymic Chinese crude drug species in Taiwan. Evaluation of the
quality of DA-Ching-Yeh and Ching-Dai. Anal Sci. 17:a423–a426.
2001.
|
|
10
|
Xu LH, Huang F, Cheng T and Wu J:
Antivirus constituents of radix of Isatis indigotica. Chin J
Nat Med. 3:359–361. 2005.
|
|
11
|
Li L, Dong TY, Li XL and Qiao CZ: Study of
quality control on herbal drugs and preparations of daqingye and
banlangen. Acta Pharm Sin. 28:229–233. 1993.(In Chinese).
|
|
12
|
Huang QS, Yoshihiro K and Natori S:
Isolation of 2-hydroxy -3-butenyl thiocyanate, epigoitrin and
adenosine from ‘banlangen’, Isatis indigotica root. Planta
Med. 42:308–310. 1981.PubMed/NCBI
|
|
13
|
Li X, He LW and Sun DD: The methods of
anti-virus extract from Radix and its use. P: CN1969923. pp. 05–30.
2007
|
|
14
|
Zuo Y, Dai M, Wang ZY and Liu J: Effects
of banlangen polysaccharide on mice resistance to Influenza virus
infection. WCJ PS. 23:666–667. 2008.
|
|
15
|
An YQ, Jia XB, Yuan HJ, Chen Y and Jin XY:
Thinking in studies on antiviral material base of Radix
isatidis. Chin Tradit Herbal Drugs. 39:616–619. 2008.
|
|
16
|
Kizu H, Shimana H and Tomimori T: Studies
on the constituents of clematis species. VI The Constituents of
Clematis stans Sieb et Zucc. Chem Pharm Bull. 43:2187–2194.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
He LW, LI X, Chen JW, Xia Y and Wang YY:
Determination of lariciresinol-4,4′-bis-O-b-D-glucopyranoside from
Radix isatidis by HPLC. Chin Tradit Herbal Drugs.
39:1895–1897. 2008.
|
|
18
|
Ehrhardt C, Hrincius ER, Korte V, Mazur I,
Droebner K, Poetter A, Dreschers S, Schmolke M, Planz O and Ludwig
S: A polyphenol rich plant extract, CYSTUS052, exerts
anti-influenza virus activity in cell culture without toxic side
effects or the tendency to induce viral resistance. Antiviral Res.
76:38–47. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yingsakmongkon S, Miyamoto D,
Sriwilaijaroen N, Fujita K, Matsumoto K, Jampangern W, Hiramatsu H,
Guo CT, Sawada T, Takahashi T, Hidari K, Suzuki T, Ito M, Ito Y and
Suzuki Y: In vitro inhibition of human influenza A virus infection
by fruit-juice concentrate of Japanese plum (Prunus mume
SIEB. et ZUCC). Biol Pharm Bull. 31:511–515. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Miyamoto D, Hasegawa S, Sriwilaijaroen N,
Yingsakmongkon S, Hiramatsu H, Takahashi T, Hidari K, Guo CT,
Sakano Y, Suzuki T and Suzuki Y: Clarithromycin inhibits progeny
virus production from human influenza virus-infected host cells.
Biol Pharm Bull. 31:217–222. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Knox YM, Suzutani T, Yosida I and Azuma M:
Anti-influenza virus activity of crude extract of Ribes
nigrum L. Phytother Res. 17:120–122. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Graham BS, Perkins MD, Wright PF and
Karzon DT: Primary respiratory syncytial virus infection in mice. J
Med Virol. 26:153–162. 1998. View Article : Google Scholar
|
|
23
|
Hui MB, Lien EJ and Trousdale MD:
Inhibition of human adenoviruses by
1-(2′-hydroxy-5′-methoxybenzylidene) amino-3-hydroxyguanidine
tosylate. Antiviral Res. 24:261–273. 1994.
|
|
24
|
Mao H, Thakur CS, Chattopadhyay S,
Silverman RH, Gudkov A and Banerjee AK: Inhibition of human
parainfluenza virus type 3 infection by novel small molecules.
Antiviral Res. 77:83–94. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ho HY, Cheng ML, Weng SF, Leu YL and Chiu
DT: Antiviral effect of epigallocatechin gallate on enterovirus 71.
J Agric Food Chem. 57:6140–6147. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kaiser L, Crump CE and Hayden FG: In vitro
activity of pleconaril and AG7088 against selected serotypes and
clinical isolates of human rhinoviruses. Antiviral Res. 7:215–220.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Reed LJ and Muench H: A simple method of
estimating fifty percent endpoints. Am J Hyg. 27:493–497. 1938.
|
|
28
|
Ludwig S, Wolff T, Ehrhardt C, Wurzer WJ,
Reinhardt J, Planz O and Pleschka S: MEK inhibition impairs
influenza B virus propagation without emergence of resistant
variants. FEBS Lett. 561:37–43. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Peng JP, Fan GR and Wu YT: Isolation and
purification of clemastanin B and indigoticoside A from Radix
isatidis by high-speed counter-current chromatography. J
Chromatogr A. 1091:89–93. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Taubenberger JK: The origin and virulence
of the 1918 ‘Spanish’ influenza virus. Proc Am Philos Soc.
150:86–112. 2006.
|
|
31
|
Mak NK, Leung CY, Wei XY, Shen XL, Wong
RN, Leung KN and Fung MC: Inhibition of RANTES expression by
indirubin in influenza virus-infected human bronchial epithelial
cells. Biochem Pharmacol. 67:167–174. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yamada H: Antiviral compositions
containing new glycoprotein from Isatis tinctoria. Acta
Pharm Sin. 1160:5991999.
|
|
33
|
Palese P: Influenza: old and new threats.
Nat Med. 10(Suppl 12): S82–S87. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
34
|
Pleschka S, Wolff T, Ehrhardt C, Hobom G,
Planz O, Rapp UR and Ludwig S: Influenza virus propagation is
impaired by inhibition of the Raf/MEK/ERK signalling cascade. Nat
Cell Biol. 3:301–305. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
35
|
Marjuki H, Alam MI, Ehrhardt C, Wagner R,
Planz O, Klenk HD, Ludwig S and Pleschka S: Membrane accumulation
of influenza A virus hemagglutinin triggers nuclear export of the
viral genome via protein kinase Calpha-mediated activation of ERK
signaling. J Biol Chem. 81:16707–16715. 2006. View Article : Google Scholar
|
|
36
|
Wu MS, Yen HR, Chang CW, Peng TY, Hsieh
CF, Chen CJ, Lin TY and Horng JT: Mechanism of action of the
suppression of influenza virus replication by Ko-Ken Tang through
inhibition of the phosphatidylinositol 3-kinase/Akt signaling
pathway and viral RNP nuclear export. J Ethnopharmacol.
134:614–623. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Mazur I, Wurzer WJ, Ehrhardt C, Pleschka
S, Puthavathana P, Silberzahn T, Wolff T, Planz O and Ludwig S:
Acetylsalicylic acid (ASA) blocks influenza virus propagation via
its NF-kappaB-inhibiting activity. Cell Microbiol. 9:1683–1694.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Bright RA, Medina MJ, Xu X, Perez-Oronoz
G, Wallis TR, Davis XM, Povinelli L, Cox NJ and Klimov AI:
Incidence of adamantane resistance among influenza A (H3N2) viruses
isolated worldwide from 1994 to 2005: a cause for concern. Lancet.
366:1175–1181. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Bright RA, Shay DK, Shu B, Cox NJ and
Klimov AI: Adamantane resistance among influenza A viruses isolated
early during the 2005–2006 influenza season in the United States.
JAMA. 295:891–894. 2006.
|
|
40
|
Dawood FS, Jain S, Finelli L, Shaw MW,
Lindstrom S, Garten RJ, Gubareva LV, Xu X, Bridges CB and Uyeki TM:
Emergence of a novel swine-origin influenza A (H1N1) virus in
humans. N Engl J Med. 360:2605–2615. 2009. View Article : Google Scholar : PubMed/NCBI
|
